Strekin AG · Small Molecule · Phase 3
CompletedTherapeutic
Population
Adults · ≥18 years
Acute idiopathic or noise-trauma SSNHL
Evidence
registry
Confidence
82%
Indications
Hearing LossSudden Sensorineural Hearing LossSensorineural Hearing Loss
See what is being studies, who is developing it, and how far it has progressed.
Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.
A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.
How records are checked